New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 25, 2014
08:41 EDTARIAARIAD at H.C upgraded to Buy from Neutral at H.C. Wainwright
H.C. Wainwright assumed coverage on ARIAD with a Buy rating from a Neutral rating based on expected Iclusig share gains and the lifting of partial clinical holds allowing investigators to look at new indications. Price target is $14.
News For ARIA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 1, 2016
07:37 EDTARIAARIAD announces FDA clearance to begin development of AP32788
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use